Showing results (401-410 of 548) with videos related to
Sort By:
Pageof 55
Clinical Journal of the American Society of Nephrology : CJASN|October 23, 2010
Equations to estimate creatinine excretion rate: the CKD epidemiology collaborationJoachim H Ix, Christina L Wassel, Lesley A Stevens, et al.Journal of Cardiac Failure|August 5, 2020
Cystatin C and Muscle Mass in Patients With Heart FailureJuan B Ivey-Miranda, Lesley A Inker, Matthew Griffin, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 1999
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril StudyW A Wilmer, L A Hebert, E J Lewis, et al.Kidney International|June 7, 2018
Serum metabolites are associated with all-cause mortality in chronic kidney diseaseJiun-Ruey Hu, Josef Coresh, Lesley A Inker, et al.Circulation|March 22, 2006
Relationship between homocysteine and mortality in chronic kidney diseaseVandana Menon, Mark J Sarnak, Tom Greene, et al.Pediatrics|June 5, 2003
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratificationRonald J Hogg, Susan Furth, Kevin V Lemley, et al.Journal of the American Society of Nephrology : JASN|February 10, 2016
Candidate Surrogate End Points for ESRD after AKIMorgan E Grams, Yingying Sang, Josef Coresh, et al.Kidney International|June 2, 1998
Predictors of GBV-C infection among patients referred for renal transplantationB V Murthy, A S Muerhoff, S M Desai, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.Journal of the American Society of Nephrology : JASN|December 15, 2015
Past Decline Versus Current eGFR and Subsequent ESRD RiskCsaba P Kovesdy, Josef Coresh, Shoshana H Ballew, et al.Pageof 55